Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000042

Chief Financial Officer acquired 18,602 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Mihir · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-17 Grant or award : show line 1 in the form +18,602 50,723 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-17 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +94,418 94,418 D
Loading xslF345X03/edgardoc.xml…